Complete Atrioventricular Septal Defect Repair in Patients With Down Syndrome Presenting Beyond Six Months

Abstract

Background

Complete atrioventricular septal defect (cAVSD) is the most common cardiac lesions associated with Down syndrome (DS). In DS, cAVSD repair is ideally performed before six months of age to prevent irreversible pulmonary artery hypertension (PAH). However, in developing countries, delayed repair is often unavoidable. We retrospectively analyzed the outcomes of cAVSD repair in DS patients presenting beyond six months of age.

Method

Between 2015 and 2019, 60 DS patients with cAVSD who underwent biventricular repair were reviewed. During the same time period 42 DS patients under 6 months of age underwent cAVSD repair. Their laboratory parameters and echocardiographic data were analyzed. Clinical findings as well as echocardiographic results at last follow-up were recorded.

Result

Median age of the cohort was eight months. There were 7/60 (11.7%) early mortalities due to right ventricular dysfunction secondary to persistent PAH (n = 4) and sepsis (n = 3). We found that right atrioventricular valve regurgitation (AVVR) grade (OR = 5.7, P = .017), postoperative serum bilirubin (OR = 4.03, P = .04), postoperative creatinine (OR = 7.06, P = .008), and right AVVR Gmax (OR = 6.08, P = .009) were independent risk factors for mortality. Mean follow-up was 1658 ± 771 days with a survival rate of 85% at 1, 5, and 10 years. Late reoperation (5.6% vs 3.7%) as well as prevalence of more than mild regurgitation was higher for the right AV valve as compared with the left AV valve (11.5% vs 1.9%). We did not find any factors associated with reoperation. All patients were clinically asymptomatic and did not have residual severe PAH.

Conclusion

Complete Atrioventricular septal defect repair in late-presenting patients with DS is feasible and yields good long-term outcomes. However, close follow-up is necessary to monitor for the late development of right AVVR.

Keywords

atrioventricular septal defects congenital heart disease Down syndrome pulmonary hypertension

Get full access to this article

View all access options for this article.

References

Konstantinov

Brizard

Buratto

. A stitch in time: age impacts survival in repair of atrioventricular septal defects. J Thorac Dis. 2023;15(2):235-237. doi:https://doi.org/10.21037/jtd-22-1664

Cai

Chen

, et al. Middle to long-term outcomes of surgical repair for atrioventricular septal defect: a single-center study. J Thorac Dis. 2022;14(10):3706-3718. doi:https://doi.org/10.21037/jtd-22-790

Saxena

Relan

Agarwal

, et al. Indian Guidelines for indications and timing of intervention for common congenital heart diseases: revised and updated consensus statement of the working group on management of congenital heart diseases. Ann Pediatr Cardiol. 2019;12(3):254-286. doi:https://doi.org/10.4103/apc.APC_32_19

Saxena

. Congenital cardiac surgery in the less privileged regions of the world. Expert Rev Cardiovasc Ther. 2009;7(12):1621–1629. doi:https://doi.org/10.1586/erc.09.141

Talwar

Singh

Chandra

Marwah

Sharma

. Challenges in delayed repair of atrioventricular septal defects. World J Pediatr Congenit Heart Surg. 2010;1(1):87–90.

Bush

Ivy

. Pulmonary hypertension in the population with down syndrome. Cardiol Ther. 2022;11(1):33–47. doi:https://doi.org/10.1007/s40119-021-00251-5. Epub 2022 Jan 16. PMID: 35037192; PMCID: PMC8933583.

Daene

De Pauw

De Meester

, et al. Outcome of down patients with repaired versus unrepaired atrioventricular septal defect. Int J Cardiol Congenit Heart Dis. 2023;12:100452. doi:https://doi.org/10.1016/j.ijcchd.2023.100452

Schulze-Neick

Penny

Redington

. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. J Thorac Cardiovasc Surg. 2001;121(6):1033–1039.

Wernovsky

Wypij

Jonas

, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995;92(8):2226–2235.

10.

Wessel

. Hemodynamic responses to perioperative pain and stress in infants. Crit Care Med. 1993;21(9 suppl):S361–S362.

11.

Delany

Gaydos

Romeo

, et al. Down syndrome and congenital heart disease: perioperative planning and management. J Congenit Cardiol. 2021;5:1–4. doi:https://doi.org/10.1186/s40949-021-00061-3

12.

Lindberg

Olsson

Jögi

Jonmarker

. How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg. 2002;123(6):1155–1163. doi:https://doi.org/10.1067/mtc.2002.121497

13.

Aly

Qattea

Othman

Nguyen

Aly

. Outcomes of atrioventricular septal defects with and without down syndrome: analysis of the national inpatient database. Cardiol Young. 2024;34(3):614–623.

14.

Lange

Guenther

Busch

Hess

Schreiber

. The presence of down syndrome is not a risk factor in complete atrioventricular septal defect repair. J Thorac Cardiovasc Surg. 2007;134(2):304–310. doi:https://doi.org/10.1016/j.jtcvs.2007.01.026

15.

A-Hay

MacNeill

Yacoub

Shore

Shinebourne

EA.

Complete atrioventricular septal defect, down syndrome, and surgical outcome: risk factors. Ann Thorac Surg. 2003;75(2):412–421. doi:https://doi.org/10.1016/S0003-4975(02)04026-2

16.

St. Louis

Jodhka

Jacobs

, et al. Contemporary outcomes of complete atrioventricular septal defect repair: analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. J Thorac Cardiovasc Surg. 2014;148(6):2526–2531. doi:https://doi.org/10.1016/j.jtcvs.2014.05.095

17.

Pfitzer

Helm

Rosenthal

Berger

Bauer

UMM

Schmitt

. Dynamics in prevalence of down syndrome in children with congenital heart disease. Eur J Pediatr. 2018;177(1):107–115. doi:https://doi.org/10.1007/s00431-017-3041-6

18.

Vis

Duffels

Winter

, et al. Down syndrome: a cardiovascular perspective. J Intellect Disabil Res. 2009;53(5):419–425.

19.

Chen

Bai

Sun

Chen

. Severe postoperative hyperbilirubinemia in congenital heart disease. Open Med (Wars). 2021;16(1):1276–1285. doi:https://doi.org/10.1515/med-2021-0316. PMID: 34541326; PMCID: PMC8409460.

20.

Aydin

Seiden

Blaufox

, et al. Acute kidney injury after surgery for congenital heart disease. Ann Thorac Surg. 2012;94(5):1589–1595.

21.

Park

Hur

Kim

, et al. Risk factors for acute kidney injury after congenital cardiac surgery in infants and children: a retrospective observational study. PLoS One. 2016;11(11):e0166328.

22.

Hirano

Ito

Yamada

, et al. Independent risk factors and 2-year outcomes of acute kidney injury after surgery for congenital heart disease. Am J Nephrol. 2017;46(3):204–209.

23.

Taylor

Carmona

Thiagarajan

, et al. Mild postoperative acute kidney injury and outcomes after surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2013;146(1):146–152.

24.

Fuhrman

Nguyen

Sanchez-de-Toledo

Priyanka

Kellum

. Postoperative acute kidney injury in young adults with congenital heart disease. Ann Thorac Surg. 2019;107(5):1416–1420.

25.

Abouelella

Habib

AlHalees

Alanazi

Ibhais

Alwadai

. Outcome of cardiac surgery in adults with congenital heart disease: a single center experience. J Saudi Heart Assoc. 2019;31(3):145–150.

26.

Baufreton

Journois

Leca

Khoury

Tamisier

Vouhé

. Ten-year experience with surgical treatment of partial atrioventricular septal defect: risk factors in the early postoperative period. J Thorac Cardiovasc Surg. 1996;112(1):14–20.

27.

Formigari

Di Donato

Gargiulo

, et al. Better surgical prognosis for patients with complete atrioventricular septal defect and Down's syndrome, Ann Thorac Surg, 2004;78(2):666–672, discussion 672, doi:https://doi.org/10.1016/j.athoracsur.2003.12.021

28.

Pontailler

Kalfa

Garcia

, et al. Reoperations for left atrioventricular valve dysfunction after repair of atrioventricular septal defect. Eur J Cardiothorac Surg. 2014;45(3):557–563. doi:https://doi.org/10.1093/ejcts/ezt392

29.

Hopper

Abman

Elia

, et al. Pediatric pulmonary hypertension network investigators. Pulmonary hypertension in children with down syndrome: results from the pediatric pulmonary hypertension network registry. J Pediatr. 2023;252:131–140.e3. doi:https://doi.org/10.1016/j.jpeds.2022.08.027

30.

Abman

Mullen

Sleeper

, et al. Characterisation of pediatric pulmonary hypertensive vascular disease from the PPHNet registry. Eur Respir J. 2021;59(1):2003337. doi:https://doi.org/10.1183/13993003.03337-2020

31.

van der Feen

Bartelds

de Boer

Berger

RMF

. Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease. Eur Heart J. 2017;38(26):2034–2041.

32.

Jančauskaitė

Rudienė

Jakutis

Geenen

Roos-Hesselink

Gumbienė

. Residual pulmonary hypertension more than 20 years after repair of shunt lesions. Medicina (Kaunas). 2020;56(6):297. doi:https://doi.org/10.3390/medicina56060297

33.

Schumacher

Marin Cuartas

Meier

, et al. Long-term results following atrioventricular septal defect repair. J Cardiothorac Surg. 2023;18(1):250. doi:https://doi.org/10.1186/s13019-023-02355-6

34.

Dodge-Khatami

Herger

Rousson

, et al. Outcomes and reoperations after total correction of complete atrio-ventricular septal defect. Eur J Cardiothorac Surg. 2008;34(4):745–750.

Complete Atrioventricular Septal Defect Repair in Patients With Down Syndrome Presenting Beyond Six Months— A Single Center Experience

Abstract

Background

Method

Result

Conclusion

Keywords

Get full access to this article

References